Addition of hepatocyte GF (HGF) neutralizing antibody or HGF inhibitor NK4 inhibited estradiol-induced endometrial cancer cell invasion, which suggests that HGF treatment increases estradiol-induced invasiveness of endometrial cancer cells. The gene discussed is HGF; the disease is endometrial cancer.